FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 21, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 21, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 40.5% of total US population have received at least 1 dose
• 26.4% of total US population are fully vaccinated
• 26.4% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 33.9%
2. New Mexico: 33.1%
3. Connecticut: 33%
4. Alaska: 32.8%
5. Vermont: 32.8%
2. New Mexico: 33.1%
3. Connecticut: 33%
4. Alaska: 32.8%
5. Vermont: 32.8%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 31 820 518 confirmed cases
• 568 874 deaths
• 568 874 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 723 863
2. Texas: 2 860 497
3. Florida: 2 178 783
4. New York: 2 010 183
5. Illinois: 1 309 455
2. Texas: 2 860 497
3. Florida: 2 178 783
4. New York: 2 010 183
5. Illinois: 1 309 455
Deaths: California has the most deaths due to COVID-19 with 61 164 reported fatalities, followed by New York with 51 711, and Texas with 49 676.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 143 283 366 confirmed cases, 3 049 638 deaths, and 82 138 454 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
2
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
3
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
4
ACCORD Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation
5